annual operating expenses:
$202.10M+$53.17M(+35.70%)Summary
- As of today (July 2, 2025), CLDX annual total operating expenses is $202.10 million, with the most recent change of +$53.17 million (+35.70%) on December 31, 2024.
- During the last 3 years, CLDX annual operating expenses has risen by +$128.30 million (+173.85%).
- CLDX annual operating expenses is now at all-time high.
Performance
CLDX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$63.43M+$6.23M(+10.89%)Summary
- As of today (July 2, 2025), CLDX quarterly total operating expenses is $63.43 million, with the most recent change of +$6.23 million (+10.89%) on March 31, 2025.
- Over the past year, CLDX quarterly operating expenses has increased by +$22.67 million (+55.61%).
- CLDX quarterly operating expenses is now at all-time high.
Performance
CLDX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CLDX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.7% | +55.6% |
| 3 y3 years | +173.8% | +164.7% |
| 5 y5 years | +247.9% | +312.9% |
CLDX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +173.8% | at high | +127.5% |
| 5 y | 5-year | at high | +254.6% | at high | +379.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
CLDX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $63.43M(+10.9%) |
| Dec 2024 | $202.10M(+35.7%) | $57.20M(+3.4%) |
| Sep 2024 | - | $55.32M(+13.3%) |
| Jun 2024 | - | $48.81M(+19.8%) |
| Mar 2024 | - | $40.76M(+3.8%) |
| Dec 2023 | $148.93M(+36.1%) | $39.26M(-8.2%) |
| Sep 2023 | - | $42.76M(+27.7%) |
| Jun 2023 | - | $33.47M(+0.1%) |
| Mar 2023 | - | $33.44M(+13.4%) |
| Dec 2022 | $109.45M(+48.3%) | $29.50M(+5.0%) |
| Sep 2022 | - | $28.10M(+0.8%) |
| Jun 2022 | - | $27.89M(+16.3%) |
| Mar 2022 | - | $23.97M(+14.6%) |
| Dec 2021 | $73.80M(+29.5%) | $20.92M(+8.0%) |
| Sep 2021 | - | $19.38M(+16.3%) |
| Jun 2021 | - | $16.66M(-1.1%) |
| Mar 2021 | - | $16.84M(+19.9%) |
| Dec 2020 | $56.99M(-1.9%) | $14.05M(-2.1%) |
| Sep 2020 | - | $14.35M(+8.4%) |
| Jun 2020 | - | $13.23M(-13.9%) |
| Mar 2020 | - | $15.36M(+13.3%) |
| Dec 2019 | $58.10M(-32.4%) | $13.56M(-6.5%) |
| Sep 2019 | - | $14.50M(+3.7%) |
| Jun 2019 | - | $13.99M(-12.8%) |
| Mar 2019 | - | $16.05M(+3.3%) |
| Dec 2018 | $85.94M(-29.6%) | $15.54M(-0.6%) |
| Sep 2018 | - | $15.64M(-42.2%) |
| Jun 2018 | - | $27.07M(-2.2%) |
| Mar 2018 | - | $27.69M(-6.4%) |
| Dec 2017 | $122.07M(-12.6%) | $29.58M(+7.6%) |
| Sep 2017 | - | $27.48M(-13.5%) |
| Jun 2017 | - | $31.76M(-4.5%) |
| Mar 2017 | - | $33.25M(-9.5%) |
| Dec 2016 | $139.70M(+3.5%) | $36.73M(+14.0%) |
| Sep 2016 | - | $32.21M(-4.6%) |
| Jun 2016 | - | $33.76M(-8.8%) |
| Mar 2016 | - | $37.01M(+5.0%) |
| Dec 2015 | $135.02M(+7.1%) | $35.23M(+5.5%) |
| Sep 2015 | - | $33.40M(-4.4%) |
| Jun 2015 | - | $34.93M(+11.0%) |
| Mar 2015 | - | $31.47M(-6.1%) |
| Dec 2014 | $126.02M(+51.4%) | $33.53M(+6.6%) |
| Sep 2014 | - | $31.44M(+7.9%) |
| Jun 2014 | - | $29.14M(-8.7%) |
| Mar 2014 | - | $31.91M(+40.3%) |
| Dec 2013 | $83.22M(+42.2%) | $22.73M(-6.2%) |
| Sep 2013 | - | $24.25M(+29.3%) |
| Jun 2013 | - | $18.75M(+7.3%) |
| Mar 2013 | - | $17.48M(+5.0%) |
| Dec 2012 | $58.50M(+34.4%) | $16.65M(+12.0%) |
| Sep 2012 | - | $14.86M(+9.1%) |
| Jun 2012 | - | $13.62M(+1.8%) |
| Mar 2012 | - | $13.38M(+134.8%) |
| Dec 2011 | $43.55M(+5.8%) | $5.70M(-58.8%) |
| Sep 2011 | - | $13.84M(+39.9%) |
| Jun 2011 | - | $9.89M(+2.3%) |
| Mar 2011 | - | $9.67M(-0.9%) |
| Dec 2010 | $41.17M(-6.9%) | $9.76M(-3.6%) |
| Sep 2010 | - | $10.12M(-3.7%) |
| Jun 2010 | - | $10.51M(-2.7%) |
| Mar 2010 | - | $10.79M(-31.7%) |
| Dec 2009 | $44.24M(+17.2%) | $15.79M(+73.3%) |
| Sep 2009 | - | $9.11M(-9.2%) |
| Jun 2009 | - | $10.04M(+8.1%) |
| Mar 2009 | - | $9.29M(+34.2%) |
| Dec 2008 | $37.74M(+123.2%) | $6.92M(-36.7%) |
| Sep 2008 | - | $10.94M(-11.2%) |
| Jun 2008 | - | $12.32M(+62.8%) |
| Mar 2008 | - | $7.57M(+62.0%) |
| Dec 2007 | $16.91M(-14.1%) | $4.67M(+5.1%) |
| Sep 2007 | - | $4.45M(+28.9%) |
| Jun 2007 | - | $3.45M(-20.7%) |
| Mar 2007 | - | $4.35M(-2214.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $19.69M(-10.3%) | -$205.60K(-103.2%) |
| Sep 2006 | - | $6.48M(-5.1%) |
| Jun 2006 | - | $6.83M(+205.3%) |
| Mar 2006 | - | $2.24M(-54.5%) |
| Dec 2005 | $21.95M(+7.4%) | $4.91M(-10.9%) |
| Sep 2005 | - | $5.51M(-0.6%) |
| Jun 2005 | - | $5.54M(+182.8%) |
| Mar 2005 | - | $1.96M(-69.1%) |
| Dec 2004 | $20.44M(+24.9%) | $6.34M(+46.0%) |
| Sep 2004 | - | $4.35M(-11.1%) |
| Jun 2004 | - | $4.89M(-2.2%) |
| Mar 2004 | - | $4.99M(+33.4%) |
| Dec 2003 | $16.37M(-22.4%) | $3.74M(-10.5%) |
| Sep 2003 | - | $4.18M(-2.1%) |
| Jun 2003 | - | $4.27M(+2.6%) |
| Mar 2003 | - | $4.17M(-5.3%) |
| Dec 2002 | $21.10M(-24.3%) | $4.40M(-11.0%) |
| Sep 2002 | - | $4.95M(-16.9%) |
| Jun 2002 | - | $5.95M(+2.7%) |
| Mar 2002 | - | $5.79M(-28.1%) |
| Dec 2001 | $27.87M(+65.0%) | $8.05M(+10.4%) |
| Sep 2001 | - | $7.30M(+4.7%) |
| Jun 2001 | - | $6.97M(+14.7%) |
| Mar 2001 | - | $6.08M(+6.5%) |
| Dec 2000 | $16.89M(+19.5%) | $5.71M(+22.9%) |
| Sep 2000 | - | $4.64M(+40.5%) |
| Jun 2000 | - | $3.30M(+1.9%) |
| Mar 2000 | - | $3.24M(-19.8%) |
| Dec 1999 | $14.14M(+34.7%) | $4.04M(+22.4%) |
| Sep 1999 | - | $3.30M(-2.9%) |
| Jun 1999 | - | $3.40M(-2.9%) |
| Mar 1999 | - | $3.50M(-2.8%) |
| Dec 1998 | $10.50M(+14.1%) | $3.60M(+24.1%) |
| Sep 1998 | - | $2.90M(+45.0%) |
| Jun 1998 | - | $2.00M(0.0%) |
| Mar 1998 | - | $2.00M(-4.8%) |
| Dec 1997 | $9.20M(-29.2%) | $2.10M(-8.7%) |
| Sep 1997 | - | $2.30M(-14.8%) |
| Jun 1997 | - | $2.70M(+22.7%) |
| Mar 1997 | - | $2.20M(-29.0%) |
| Dec 1996 | $13.00M(-11.0%) | $3.10M(+19.2%) |
| Sep 1996 | - | $2.60M(-44.7%) |
| Jun 1996 | - | $4.70M(+80.8%) |
| Mar 1996 | - | $2.60M(-33.3%) |
| Dec 1995 | $14.60M(-4.6%) | $3.90M(+5.4%) |
| Sep 1995 | - | $3.70M(+8.8%) |
| Jun 1995 | - | $3.40M(-5.6%) |
| Mar 1995 | - | $3.60M(+24.1%) |
| Dec 1994 | $15.30M(-9.5%) | $2.90M(-21.6%) |
| Sep 1994 | - | $3.70M(-15.9%) |
| Jun 1994 | - | $4.40M(+2.3%) |
| Mar 1994 | - | $4.30M(+2.4%) |
| Dec 1993 | $16.90M(+57.9%) | $4.20M(-10.6%) |
| Sep 1993 | - | $4.70M(+9.3%) |
| Jun 1993 | - | $4.30M(+4.9%) |
| Mar 1993 | - | $4.10M(-2.4%) |
| Dec 1992 | $10.70M(-25.2%) | - |
| Oct 1992 | - | $4.20M(+20.0%) |
| Jul 1992 | - | $3.50M(-14.6%) |
| Apr 1992 | - | $4.10M(+13.9%) |
| Apr 1992 | $14.30M(+5.9%) | - |
| Jan 1992 | - | $3.60M(+2.9%) |
| Oct 1991 | - | $3.50M(+12.9%) |
| Jul 1991 | - | $3.10M(-8.8%) |
| Apr 1991 | $13.50M(+12.5%) | $3.40M(+3.0%) |
| Jan 1991 | - | $3.30M(-2.9%) |
| Oct 1990 | - | $3.40M(0.0%) |
| Jul 1990 | - | $3.40M(+9.7%) |
| Apr 1990 | $12.00M(+39.5%) | $3.10M(-8.8%) |
| Jan 1990 | - | $3.40M |
| Apr 1989 | $8.60M(+36.5%) | - |
| Apr 1988 | $6.30M(+61.5%) | - |
| Apr 1987 | $3.90M(+95.0%) | - |
| Apr 1986 | $2.00M | - |
FAQ
- What is Celldex Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Celldex Therapeutics?
- What is Celldex Therapeutics annual operating expenses year-on-year change?
- What is Celldex Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly operating expenses year-on-year change?
What is Celldex Therapeutics annual total operating expenses?
The current annual operating expenses of CLDX is $202.10M
What is the all time high annual operating expenses for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total operating expenses is $202.10M
What is Celldex Therapeutics annual operating expenses year-on-year change?
Over the past year, CLDX annual total operating expenses has changed by +$53.17M (+35.70%)
What is Celldex Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CLDX is $63.43M
What is the all time high quarterly operating expenses for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total operating expenses is $63.43M
What is Celldex Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CLDX quarterly total operating expenses has changed by +$22.67M (+55.61%)